JNJ

#16
Johnson & Johnson
234.61 USD
+0.07%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
234.25
235.28
Jahresspanne
146.12
251.71
Tagesänderung
+0.07%
Monatliche Änderung
-1.38%
6 month change
+21.43%
Jahresänderung
+48.72%
Vorheriger Schlusskurs
234.45
Eröffnung
234.98
Bid
Ask
Tief
234.25
High
235.28
Volumen
1 421
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 565.39 B
  • Employee 141 K
  • Founded N/A
  • CEO Joaquin Duato
  • Website www.jnj.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BMHYD1
  • Industry Arzneimittelhersteller – allgemein
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
18.82
Preis-Umsatz-Verhältnis
5.35
Dividende je Aktie
5.14
Dividendenrendite in %
2.48

Johnson & Johnson

Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA. Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings.

Nachrichten